Veradigm shares to be delisted

Veradigm, previously known as Allscripts, said it received a notice from Nasdaq stating that its shares would be delisted due to noncompliance. 

According to Veradigm, this is because the company did not file its annual report on form 10-K for the year ending Dec. 31, its quarterly report on form 10-Q for the quarter ending March 31, or a quarterly report on form 10-Q for the quarter ending on June 30, 2023.

The company was supposed to file these forms before the expiration of a 180-day exception period previously granted by Nasdaq, according to a Sept. 22 news release from Veradigm.

Veradigm said it could not file due to "internal control failures that primarily stem from accounting processes and a software tool," according to the release. 

Veradigm is looking to appeal Nasdaq's decision.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars